Cardiovascular
🇪🇺 EMAEMA news and analysis for pharmaceutical BD, investment, and market access
Access global pharma market insights on cardiovascular drug development, clinical trials, regulatory approvals, and M&A activity. Stay ahead.
Showing 1–3 of 3 articles
Quick answer
NovaPharmaNews Cardiovascular hub for EMA covers 3 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
CVRx Enrolls First Patient in BENEFIT-HF Heart Failure Trial Testing Barostim Device
SQ Innovation's Lasix ONYU Subcutaneous Heart Failure Trial Results to Be Presented at Heart Failure 2026
Getinge Receives CE Mark for Cardiohelp II ECLS System and EU MDR Approval for Intergard Synergy Vascular Graft
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.